The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Eculizumab
Australian Public Assessment Report
Device/Product Name
Soliris
Active ingredients
Eculizumab
AusPAR Date
Published
Submission Number
PM-2019-04825-1-1
Submission Type
Extension of indications
Decision
Approved